Aaron S. Rosenberg

3.1k total citations
87 papers, 1.9k citations indexed

About

Aaron S. Rosenberg is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Aaron S. Rosenberg has authored 87 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 29 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in Aaron S. Rosenberg's work include Multiple Myeloma Research and Treatments (26 papers), Protein Degradation and Inhibitors (14 papers) and Lymphoma Diagnosis and Treatment (14 papers). Aaron S. Rosenberg is often cited by papers focused on Multiple Myeloma Research and Treatments (26 papers), Protein Degradation and Inhibitors (14 papers) and Lymphoma Diagnosis and Treatment (14 papers). Aaron S. Rosenberg collaborates with scholars based in United States, Thailand and Australia. Aaron S. Rosenberg's co-authors include A Singer, Alfred Singer, Theresa H.M. Keegan, Toshiaki Mizuochi, S O Sharrow, Ann Brunson, T I Munitz, Qian Li, Brian A. Jonas and Melanie Goldfarb and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Aaron S. Rosenberg

81 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron S. Rosenberg United States 24 694 468 458 438 229 87 1.9k
Ludvig A. Munthe Norway 22 937 1.4× 393 0.8× 567 1.2× 482 1.1× 675 2.9× 76 2.4k
Kiyoshi Kitano Japan 25 483 0.7× 196 0.4× 599 1.3× 266 0.6× 192 0.8× 92 1.7k
Dongsik Bang South Korea 29 374 0.5× 461 1.0× 375 0.8× 177 0.4× 180 0.8× 167 3.3k
Gary Sinclair Canada 13 1.4k 1.9× 578 1.2× 740 1.6× 154 0.4× 100 0.4× 25 2.3k
Jaroslav Štěrba Czechia 22 201 0.3× 604 1.3× 191 0.4× 469 1.1× 136 0.6× 148 1.7k
T. K. Chan China 23 218 0.3× 262 0.6× 431 0.9× 499 1.1× 184 0.8× 71 1.8k
Tayfun Güngör Switzerland 26 842 1.2× 365 0.8× 1.1k 2.4× 193 0.4× 163 0.7× 88 2.4k
Mikkel Faurschou Denmark 22 1.1k 1.6× 449 1.0× 153 0.3× 118 0.3× 164 0.7× 59 2.7k
Leonard Ellman United States 24 711 1.0× 299 0.6× 525 1.1× 214 0.5× 193 0.8× 61 1.8k
Randi Isaacs United States 22 217 0.3× 588 1.3× 276 0.6× 582 1.3× 183 0.8× 41 1.6k

Countries citing papers authored by Aaron S. Rosenberg

Since Specialization
Citations

This map shows the geographic impact of Aaron S. Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron S. Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron S. Rosenberg more than expected).

Fields of papers citing papers by Aaron S. Rosenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron S. Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron S. Rosenberg. The network helps show where Aaron S. Rosenberg may publish in the future.

Co-authorship network of co-authors of Aaron S. Rosenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron S. Rosenberg. A scholar is included among the top collaborators of Aaron S. Rosenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron S. Rosenberg. Aaron S. Rosenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosenberg, Aaron S., Emanual Maverakis, Caitlin Costello, et al.. (2025). Clarithromycin, ixazomib, pomalidomide, dexamethasone for relapsed/refractory myeloma: survival and correlative analysis. PubMed. 2(3). 100067–100067.
2.
Wilson, Machelle, et al.. (2025). Impact of quadruplet induction therapy on stem cell mobilization yields in newly diagnosed multiple myeloma. Transfusion Clinique et Biologique. 32(2). 195–198.
3.
Jonas, Brian A., Zarir E. Karanjawala, Mehrdad Abedi, et al.. (2024). Updated Results of a Phase I Study of Uproleselan Combined with Azacitidine and Venetoclax for the Treatment of Older or Unfit Patients with Treatment Naïve Acute Myeloid Leukemia. Blood. 144(Supplement 1). 1503–1503. 1 indexed citations
4.
Rosenberg, Aaron S., et al.. (2024). Safety outcomes of teclistamab accelerated dose escalation. Journal of Oncology Pharmacy Practice. 31(6). 977–982. 3 indexed citations
5.
Banerjee, Rahul, Rachael Sexton, Aaron S. Rosenberg, et al.. (2024). Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis. Blood. 145(1). 75–84. 3 indexed citations
6.
Rosenberg, Aaron S., et al.. (2024). Practical insights into bispecific antibody therapy in multiple myeloma. Expert Review of Anticancer Therapy. 24(12). 1209–1219. 1 indexed citations
7.
Lo, Mimi, Rebecca Young, Ila M. Saunders, et al.. (2023). Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myeloma. Journal of Oncology Pharmacy Practice. 29(7). 1715–1724. 1 indexed citations
8.
Brunson, Ann, Aaron S. Rosenberg, Sara J. Schonfeld, et al.. (2023). Utilization of Autologous Hematopoietic Cell Transplantation Over Time in Multiple Myeloma: A Population-Based Study. Clinical Lymphoma Myeloma & Leukemia. 24(4). e119–e129. 2 indexed citations
9.
Rosenberg, Aaron S., Ann Brunson, Joseph M. Tuscano, et al.. (2021). Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients. Blood Cancer Journal. 11(1). 5–5. 13 indexed citations
10.
Whitney, Robin L., et al.. (2021). Trust and shared decision‐making among individuals with multiple myeloma: A qualitative study. Cancer Medicine. 10(22). 8040–8057. 19 indexed citations
11.
DAVIS, JULIAN R., et al.. (2020). A Phase I Study of Everolimus and Bendamustine in Patients With Relapsed/Refractory Lymphoid Hematologic Malignancies. Clinical Lymphoma Myeloma & Leukemia. 20(7). 453–458. 3 indexed citations
12.
Poh, Christina, Paul Frankel, Christopher Ruel, et al.. (2019). Blinatumomab/Lenalidomide in Relapsed/Refractory Non-Hodgkin's Lymphoma: A Phase I California Cancer Consortium Study of Safety, Efficacy and Immune Correlative Analysis. Blood. 134(Supplement_1). 760–760. 25 indexed citations
13.
14.
Goldfarb, Melanie, Aaron S. Rosenberg, Qian Li, & Theresa H.M. Keegan. (2017). Impact of latency time on survival for adolescents and young adults with a second primary malignancy. Cancer. 124(6). 1260–1268. 14 indexed citations
15.
16.
Rosenberg, Aaron S., Thierry Façon, Safiya Abouzaid, et al.. (2017). Morbid Progression Is Common Among Patients with Multiple Myeloma and Is Associated with Shortened Overall Survival: Validation of the Progression-Free Survival Endpoint. Blood. 130. 3113–3113. 1 indexed citations
17.
Rosenberg, Aaron S., Robin Ruthazer, Jessica K. Paulus, et al.. (2016). Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders. Clinical Lymphoma Myeloma & Leukemia. 16(12). 684–692.e3. 13 indexed citations
18.
Rosenberg, Aaron S., Scott Bainbridge, Roma Pahwa, & Ishwarlal Jialal. (2016). Investigation into the interference of the monoclonal antibody daratumumab on the free light chain assay. Clinical Biochemistry. 49(15). 1202–1204. 13 indexed citations
19.
Rosenberg, Aaron S., Toshiaki Mizuochi, & Alfred Singer. (1988). Evidence for involvement of dual-function T cells in rejection of MHC class I disparate skin grafts. Assessment of MHC class I alloantigens as in vivo helper determinants.. The Journal of Experimental Medicine. 168(1). 33–45. 42 indexed citations
20.
Rosenberg, Aaron S., et al.. (1966). Rabies with an incubation period of 19 years and 6 months.. 11(6). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ludvig A. Munthe Breakdown of academic impact, for papers by Kiyoshi Kitano Breakdown of academic impact, for papers by Dongsik Bang Breakdown of academic impact, for papers by Gary Sinclair Breakdown of academic impact, for papers by Jaroslav Štěrba Breakdown of academic impact, for papers by T. K. Chan Breakdown of academic impact, for papers by Tayfun Güngör Breakdown of academic impact, for papers by Mikkel Faurschou Breakdown of academic impact, for papers by Leonard Ellman Breakdown of academic impact, for papers by Randi Isaacs
Rankless by CCL
2026